Inhibrx Inc (INBX)
34.07
-0.09
(-0.26%)
USD |
NASDAQ |
Apr 30, 16:00
34.07
0.00 (0.00%)
After-Hours: 20:00
Inhibrx Profit Margin (Quarterly): -5.73K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.73K% |
| September 30, 2023 | -43.52K% |
| June 30, 2023 | -156.8K% |
| March 31, 2023 | -287.7K% |
| December 31, 2022 | -14.93K% |
| September 30, 2022 | -12.71K% |
| June 30, 2022 | -5.31K% |
| March 31, 2022 | -3.42K% |
| December 31, 2021 | -747.1% |
| September 30, 2021 | -820.6% |
| June 30, 2021 | -2.26K% |
| Date | Value |
|---|---|
| March 31, 2021 | -2.24K% |
| December 31, 2020 | -635.8% |
| September 30, 2020 | -351.8% |
| June 30, 2020 | -536.4% |
| March 31, 2020 | -2.30K% |
| December 31, 2019 | -6.11K% |
| September 30, 2019 | -2.54K% |
| June 30, 2019 | -1.11K% |
| March 31, 2019 | -54.71% |
| June 30, 2018 | -286.2% |
| March 31, 2018 | -374.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-287.7K%
Minimum
Mar 2023
-351.8%
Maximum
Sep 2020
-28.94K%
Average
-2.54K%
Median
Sep 2019
Profit Margin (Quarterly) Benchmarks
| Axonics Inc | 5.99% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -544.9% |
| Return on Assets | -83.90% |
| Return on Invested Capital | -97.01% |
| Operating Margin (Quarterly) | -5.40K% |
| Return on Net Operating Assets | -1.18K% |